Search

everythinglearnresearchcommunity

for

Search:↓

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

The document is a detailed medical reference on skin and genetic disorders.

Hibiscus has medicinal benefits but can be toxic in high doses and is unsafe for pregnant women and infants.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Many women with hard-to-treat acne also have PCOS.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

PCOS has many symptoms, with high androgen levels being the most common.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.